Evaluation of Tobramycin Tear Concentrations of TOBRADEX [tobramycin 0.3% / dexamethasone 0.1%] Ophthalmic Suspension, Tobramycin 0.3% / Dexamethasone 0.05% Ophthalmic Suspension Versus TOBREX [tobramycin] Ophthalmic Solution in Normal Volunteers.

Trial Profile

Evaluation of Tobramycin Tear Concentrations of TOBRADEX [tobramycin 0.3% / dexamethasone 0.1%] Ophthalmic Suspension, Tobramycin 0.3% / Dexamethasone 0.05% Ophthalmic Suspension Versus TOBREX [tobramycin] Ophthalmic Solution in Normal Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Mar 2010

At a glance

  • Drugs Tobramycin; Tobramycin/dexamethasone
  • Indications Bacterial infections; Ophthalmic infections
  • Focus Pharmacokinetics
  • Sponsors Alcon
  • Most Recent Events

    • 26 Mar 2010 Actual number of patients added to 21 as reported by ClinicalTrials.gov.
    • 26 Mar 2010 Actual end date added to 1 Jun 2008 as reported by ClinicalTrials.gov.
    • 03 Mar 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top